A Study of Tafasitamab and Lenalidomide in People With Mantle Cell Lymphoma
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT05788289
- Phase
- PHASE2
- Status
- Terminated
Conditions
- MCL
- Mantle Cell Lymphoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Tafasitamab — DRUGParticipants will receive treatment with intravenous tafasitamab and oral lenalidomide for up to 12 cycles. Each cycle is 28 days in length.
- Lenalidomide — DRUGLenalidomide will be self-administered by patients orally on days 1-21 of each 28-day cycle of induction (cycles 1 through 12).
Study Details
The purpose of this study is to determine if the combination of tafasitamab and lenalidomide is an effective treatment for relapsed or refractory Mantle Cell Lymphoma.
Key Dates
- Start date
- Mar 14, 2023
- Status verified
- May 2025
- Primary completion
- Aug 1, 2024
- Completion
- Aug 1, 2024
Study Design
- Enrollment
- 4 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Participants with Mantle Cell LymphomaParticipants have a diagnosis of Mantle Cell Lymphoma have previously failed or could not tolerate Bruton's tyrosine kinase inhibitors/BTKi
Primary Outcome Measure
Overall Response Rate/ORR [ Time Frame: completion of 12 cycles of treatment (each cycle is 28 days) or at treatment discontinuation, whichever comes first ]
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge (All protocol activities) | Basking Ridge | New Jersey | 07920 | - |
| Memorial Sloan Kettering Monmouth (All protocol activities) | Middletown | New Jersey | 07748 | - |
| Memorial Sloan Kettering Bergen (All protocol activities) | Montvale | New Jersey | 07645 | - |
| Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities) | Commack | New York | 11725 | - |
| Memorial Sloan Kettering Westchester (All protocol activities) | Harrison | New York | 10604 | - |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York | New York | 10065 | - |
| Memorial Sloan Kettering Nassau (All protocol activities) | Rockville Centre | New York | 11553 | - |
Find similar trials in Basking Ridge, NJ
By research site
Memorial Sloan Kettering Basking Ridge (All protocol activities)· Basking Ridge, NJMemorial Sloan Kettering Monmouth (All protocol activities)· Middletown, NJMemorial Sloan Kettering Bergen (All protocol activities)· Montvale, NJMemorial Sloan Kettering Suffolk- Commack (All Protocol Activities)· Commack, NYMemorial Sloan Kettering Westchester (All protocol activities)· Harrison, NYMemorial Sloan Kettering Cancer Center (All Protocol Activities)· New York, NY
Related Studies
- A Long-term Extension Study of PCI-32765 (Ibrutinib)PHASE3 · Recruiting · Janssen Research & Development, LLC · Duarte, California
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin LymphomaPHASE1/PHASE2 · Recruiting · New York Medical College · Valhalla, New York
- Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell LymphomaPHASE2 · Recruiting · Academic and Community Cancer Research United · New Orleans, Louisiana